Skip to main content

Combination Drugs

How they work: Combination therapies put multiple drug classes into a single medication. Combinations can be injectable (i.e. GLP-1 agonists with basal insulin in a single injection) or “fixed-dose combination” tablets that can be taken orally (i.e.  metformin combined with an SGLT-2 inhibitor into a single pill). Typically, they are meant to improve efficacy and potentially reduce side effects compared to taking multiple drugs separately. It also increases convenience for patients and has the potential to decrease co-pays for multiple medications.

Approved Drugs:

  • Xultophy (insulin degludec + liraglutide)

  • Xigduo XR (dapagliflozin + metformin extended release)

  • Glyxambi (empagliflozin + linagliptin)

  • Synjardy (empagliflozin + metformin)

  • Soliqua (insulin glargine + lixisenatide)

  • Steglujan (ertugliflozin + sitagliptin)

  • Segluromet (ertugliflozin + metformin)

  • Eucreas (vildagliptin + metformin)*

*Approved in Europe Only

Last updated: February 28, 2018